You have 9 free searches left this month | for more free features.

City

Chengdu (1)

Guangzhou (1)

Condition

Coronary Microvascular Perfusion in Patients With Ischemic Heart Disease (1)

Diabetic Nephropathy (1)

Percutaneous Coronary Intervention (1)

Prostaglandin E1 (1)

Overall Status

Unknown status (2)

Completed (1)

Sign in for free

Phase

phase 4 (2)

phase 3 (1)

Sponsor

First Affiliated Hospital, Sun Yat-Sen University (1)

Tongji Hospital (1)

West China Hospital (1)

Collaborator

Intervention

lipo-pge1 (3)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (3)

Study Type

Interventional (3)

lipo-pge1

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Coronary Microvascular Perfusion in Patients With Ischemic Heart Disease Trial (Lipo-PGE1)

Unknown status

Coronary Microvascular Perfusion in Patients With Ischemic Heart Disease

Lipo-PGE1

(no location specified)

May 17, 2017

Diabetic Nephropathy Trial in Chengdu (Lipo-PGE1)

Completed

Has Results

Diabetic Nephropathy

Lipo-PGE1

Chengdu, Sichuan, China

Zhichengli

Nov 2, 2016

Prostaglandin E1, Percutaneous Coronary Intervention Trial in Guangzhou (lipo-PGE1)

Unknown status

Prostaglandin E1
Percutaneous Coronary Intervention

lipo-PGE1

Guangzhou, Guangdong, China

First Affiliated Hospital, Sun Yat-sen University

Nov 22, 2010